Table 3.

Percentages of participants with local and systemic reactions by day after the third vaccination.

	Adverse Reaction	Day 0	Day 1	Day 2	Day 3	Day 4	Day 5	Day 6
Local	Maximal diameter of redness or swelling at the injection site, cm
	≥ 1 cm and < 5 cm	2 (12.5)	1 (6.25)	1 (6.25)	4 (25)	4 (25)	2 (12.5)	0 (0)
	≥ 5 cm and < 10 cm	3 (18.75)	6 (37.5)	3 (18.75)	2 (12.5)	1 (6.25)	0 (0)	0 (0)
	≥10 cm	0 (0)	2 (12.5)	3 (18.75)	1 (6.25)	1 (6.25)	0 (0)	0 (0)
	Mild soreness in arm	5 (31.25)	3 (18.75)	2 (12.5)	6 (37.5)	4 (25)	2 (12.5)	1 (6.25)
	Moderate soreness in arm	2 (12.5)	5 (31.25)	4 (25)	0 (0)	0 (0)	0 (0)	0 (0)
	Severe soreness in arm	0 (0)	1 (6.25)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Systemic	Nausea	0 (0)	0 (0)	1 (6.25)	1 (6.25)	1 (6.25)	1 (6.25)	1 (6.25)
	Headache	1 (6.25)	2 (12.5)	3 (18.75)	2 (12.5)	2 (12.5)	2 (12.5)	2 (12.5)
	Myalgia	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
	Arthralgia	0 (0)	1 (6.25)	1 (6.25)	0 (0)	0 (0)	0 (0)	0 (0)
	Fatigue	2 (12.5)	5 (31.25)	4 (25)	2 (12.5)	1 (6.25)	1 (6.25)	3 (18.75)
	Temperature ≥38°C	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)

All data are presented as n (%) of participants (N = 16).